AR060796A1 - Composicion farmaceutica que comprende la proteina nmb0938 - Google Patents
Composicion farmaceutica que comprende la proteina nmb0938Info
- Publication number
- AR060796A1 AR060796A1 ARP070101322A ARP070101322A AR060796A1 AR 060796 A1 AR060796 A1 AR 060796A1 AR P070101322 A ARP070101322 A AR P070101322A AR P070101322 A ARP070101322 A AR P070101322A AR 060796 A1 AR060796 A1 AR 060796A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- nmb0938
- pharmaceutical composition
- caused
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se relaciona con el campo de la medicina, particularmente con el desarrollo de una composicion farmacéutica que comprende la proteína NMB0938. La composicion de la presente confiere proteccion contra diferentes enfermedades, causadas o no por patogenos. La proteína NMB0938 se identifico como componente de las preparaciones de vesículas de membrana externa (VME) de Neisseria meningitidis, se obtuvo mediante la tecnología del ácido desoxirribonucleico (ADN) recombinante y se evaluo su inmunogenicidad y actividad protectora en modelos animales. Por el elevado grado de conservacion del gen que codifica para la proteína NMB0938, la composicion que la comprende posee alto valor como antígeno inductor de una respuesta inmune de amplia reactividad. La composicion es aplicable en la medicina humana.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20060074A CU23572A1 (es) | 2006-03-31 | 2006-03-31 | Composición farmacéutica que comprende la proteína nmb0938 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR060796A1 true AR060796A1 (es) | 2008-07-16 |
Family
ID=38461832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP070101322A AR060796A1 (es) | 2006-03-31 | 2007-03-29 | Composicion farmaceutica que comprende la proteina nmb0938 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090297547A1 (es) |
| EP (1) | EP2011511A2 (es) |
| KR (1) | KR20080106985A (es) |
| CN (1) | CN101448522A (es) |
| AR (1) | AR060796A1 (es) |
| AU (1) | AU2007234213A1 (es) |
| BR (1) | BRPI0710064A2 (es) |
| CA (1) | CA2649321A1 (es) |
| CU (1) | CU23572A1 (es) |
| MX (1) | MX2008012664A (es) |
| NO (1) | NO20084524L (es) |
| WO (1) | WO2007112702A2 (es) |
| ZA (1) | ZA200808769B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104079247B (zh) | 2013-03-26 | 2018-02-09 | 杜比实验室特许公司 | 均衡器控制器和控制方法以及音频再现设备 |
| CN107093991B (zh) | 2013-03-26 | 2020-10-09 | 杜比实验室特许公司 | 基于目标响度的响度归一化方法和设备 |
| DK3506935T3 (en) | 2016-09-02 | 2024-04-02 | Sanofi Pasteur Inc | Neisseria meningitidis-vaccine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ541361A (en) * | 1998-05-01 | 2008-04-30 | Inst Genomic Research | Neisseria meningitidis antigens and compositions relating to SEQ ID Nos:2916, 2918 and 2920 |
| NZ545647A (en) * | 1999-05-19 | 2008-02-29 | Chiron Srl | Combination neisserial compositions |
| CU23236A1 (es) * | 2003-12-03 | 2007-09-26 | Ct Ingenieria Genetica Biotech | PROTEINA NMB0928 Y SU USO EN FORMULACIONES FARMACéUTICAS P |
-
2006
- 2006-03-31 CU CU20060074A patent/CU23572A1/es unknown
-
2007
- 2007-03-29 MX MX2008012664A patent/MX2008012664A/es not_active Application Discontinuation
- 2007-03-29 US US12/295,436 patent/US20090297547A1/en not_active Abandoned
- 2007-03-29 AR ARP070101322A patent/AR060796A1/es not_active Application Discontinuation
- 2007-03-29 CN CNA2007800183602A patent/CN101448522A/zh active Pending
- 2007-03-29 AU AU2007234213A patent/AU2007234213A1/en not_active Abandoned
- 2007-03-29 WO PCT/CU2007/000011 patent/WO2007112702A2/es active Search and Examination
- 2007-03-29 KR KR1020087026337A patent/KR20080106985A/ko not_active Application Discontinuation
- 2007-03-29 EP EP07721807A patent/EP2011511A2/en not_active Withdrawn
- 2007-03-29 BR BRPI0710064-7A patent/BRPI0710064A2/pt not_active IP Right Cessation
- 2007-03-29 CA CA002649321A patent/CA2649321A1/en not_active Abandoned
-
2008
- 2008-10-14 ZA ZA200808760A patent/ZA200808769B/xx unknown
- 2008-10-28 NO NO20084524A patent/NO20084524L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CU23572A1 (es) | 2010-09-30 |
| NO20084524L (no) | 2008-12-03 |
| WO2007112702A2 (es) | 2007-10-11 |
| CN101448522A (zh) | 2009-06-03 |
| ZA200808769B (en) | 2009-09-11 |
| US20090297547A1 (en) | 2009-12-03 |
| KR20080106985A (ko) | 2008-12-09 |
| EP2011511A2 (en) | 2009-01-07 |
| BRPI0710064A2 (pt) | 2011-08-02 |
| AU2007234213A1 (en) | 2007-10-11 |
| WO2007112702A3 (es) | 2007-11-22 |
| MX2008012664A (es) | 2008-10-13 |
| CA2649321A1 (en) | 2007-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mohn et al. | Immune responses after live attenuated influenza vaccination | |
| McAuley et al. | Activation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and disease | |
| BR112016003358A2 (pt) | método para aumentar a expressão de proteínas codificadas por rna | |
| AR079197A1 (es) | Polipeptidos inmunomoduladores derivados de la il-2 y su uso terapeutico en cancer y en infecciones cronicas | |
| CY1118373T1 (el) | Υψηλης συγκεντρωσης υγρες μορφοποιησεις anti-tnfa αντισωματος | |
| BRPI0924460A2 (pt) | composição farmacêutica para uso em oftalmologia médica e veterinária | |
| BR112012024379A2 (pt) | "peptídeos glucagon, seu uso, bem como composição farmacêutica" | |
| CO7010783A2 (es) | Proteína naglu humana recombinante y usos de la misma | |
| BR112014006684A2 (pt) | análogos de glucagon | |
| BRPI0416796A (pt) | compostos orgánicos | |
| EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
| BR112012022800A2 (pt) | composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica | |
| ECSP11011367A (es) | Composición farmacéutica | |
| CU23923B1 (es) | Polipéptidos derivados de la il-2 con actividad agonista | |
| BRPI0816784A8 (pt) | Fatores neuro-endócrinos para o tratamento de doenças degenerativas | |
| BR112015010756A8 (pt) | vacina de emergência baseada em peptídeo sintético contra doença do pé-e-boca (fmd) | |
| UA114719C2 (uk) | Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv | |
| BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
| MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
| MX351380B (es) | Composiciones y metodos de vacuna de tipo ib de virus de diarrea viral de bovino. | |
| BR112012013164A2 (pt) | composições farmacêuticas para o estímulo de células-tronco | |
| BRPI0606140A2 (pt) | tiazolidinonas, preparação e uso das mesmas como medicamento | |
| AR060796A1 (es) | Composicion farmaceutica que comprende la proteina nmb0938 | |
| BR112014020184A8 (pt) | Preparação farmacêutica que contém anlodipina e ra-mipril | |
| CU23575A1 (es) | Composición farmacéutica que comprende la proteína nmb0606 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |